Skip to main content
Top
Published in: Diabetologia 5/2013

01-05-2013 | Article

Mouse strain-dependent variation in obesity and glucose homeostasis in response to high-fat feeding

Authors: M. K. Montgomery, N. L. Hallahan, S. H. Brown, M. Liu, T. W. Mitchell, G. J. Cooney, N. Turner

Published in: Diabetologia | Issue 5/2013

Login to get access

Abstract

Aims/hypothesis

Metabolic disorders are commonly investigated using knockout and transgenic mouse models. A variety of mouse strains have been used for this purpose. However, mouse strains can differ in their inherent propensities to develop metabolic disease, which may affect the experimental outcomes of metabolic studies. We have investigated strain-dependent differences in the susceptibility to diet-induced obesity and insulin resistance in five commonly used inbred mouse strains (C57BL/6J, 129X1/SvJ, BALB/c, DBA/2 and FVB/N).

Methods

Mice were fed either a low-fat or a high-fat diet (HFD) for 8 weeks. Whole-body energy expenditure and body composition were then determined. Tissues were used to measure markers of mitochondrial metabolism, inflammation, oxidative stress and lipid accumulation.

Results

BL6, 129X1, DBA/2 and FVB/N mice were all susceptible to varying degrees to HFD-induced obesity, glucose intolerance and insulin resistance, but BALB/c mice exhibited some protection from these detrimental effects. This protection could not be explained by differences in mitochondrial metabolism or oxidative stress in liver or muscle, or inflammation in adipose tissue. Interestingly, in contrast with the other strains, BALB/c mice did not accumulate excess lipid (triacylglycerols and diacylglycerols) in the liver; this is potentially related to lower fatty acid uptake rather than differences in lipogenesis or lipid oxidation.

Conclusions/interpretation

Collectively, our findings indicate that most mouse strains develop metabolic defects on an HFD. However, there are inherent differences between strains, and thus the genetic background needs to be considered carefully in metabolic studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Andrikopoulos S, Massa CM, Aston-Mourney K et al (2005) Differential effect of inbred mouse strain (C57BL/6, DBA/2, 129T2) on insulin secretory function in response to a high fat diet. J Endocrinol 187:45–53PubMedCrossRef Andrikopoulos S, Massa CM, Aston-Mourney K et al (2005) Differential effect of inbred mouse strain (C57BL/6, DBA/2, 129T2) on insulin secretory function in response to a high fat diet. J Endocrinol 187:45–53PubMedCrossRef
2.
go back to reference Berglund ED, Li CY, Poffenberger G et al (2008) Glucose metabolism in vivo in four commonly used inbred mouse strains. Diabetes 57:1790–1799PubMedCrossRef Berglund ED, Li CY, Poffenberger G et al (2008) Glucose metabolism in vivo in four commonly used inbred mouse strains. Diabetes 57:1790–1799PubMedCrossRef
3.
go back to reference Boudina S, Sena S, Sloan C et al (2012) Early mitochondrial adaptations in skeletal muscle to diet-induced obesity are strain dependent and determine oxidative stress and energy expenditure but not insulin sensitivity. Endocrinology 153:2677–2688PubMedCrossRef Boudina S, Sena S, Sloan C et al (2012) Early mitochondrial adaptations in skeletal muscle to diet-induced obesity are strain dependent and determine oxidative stress and energy expenditure but not insulin sensitivity. Endocrinology 153:2677–2688PubMedCrossRef
4.
go back to reference Goren HJ, Kulkarni RN, Kahn CR (2004) Glucose homeostasis and tissue transcript content of insulin signaling intermediates in four inbred strains of mice: C57BL/6, C57BLKS/6, DBA/2, and 129X1. Endocrinology 145:3307–3323PubMedCrossRef Goren HJ, Kulkarni RN, Kahn CR (2004) Glucose homeostasis and tissue transcript content of insulin signaling intermediates in four inbred strains of mice: C57BL/6, C57BLKS/6, DBA/2, and 129X1. Endocrinology 145:3307–3323PubMedCrossRef
5.
go back to reference Paigen B (1995) Genetics of responsiveness to high-fat and high-cholesterol diets in the mouse. Am J Clin Nutr 62:458S–462SPubMed Paigen B (1995) Genetics of responsiveness to high-fat and high-cholesterol diets in the mouse. Am J Clin Nutr 62:458S–462SPubMed
6.
go back to reference Metlakunta AS, Sahu M, Sahu A (2008) Hypothalamic phosphatidylinositol 3-kinase pathway of leptin signaling is impaired during the development of diet-induced obesity in FVB/N mice. Endocrinology 149:1121–1128PubMedCrossRef Metlakunta AS, Sahu M, Sahu A (2008) Hypothalamic phosphatidylinositol 3-kinase pathway of leptin signaling is impaired during the development of diet-induced obesity in FVB/N mice. Endocrinology 149:1121–1128PubMedCrossRef
7.
go back to reference Fearnside JF, Dumas ME, Rothwell AR et al (2008) Phylometabonomic patterns of adaptation to high fat diet feeding in inbred mice. PLoS One 3:e1668PubMedCrossRef Fearnside JF, Dumas ME, Rothwell AR et al (2008) Phylometabonomic patterns of adaptation to high fat diet feeding in inbred mice. PLoS One 3:e1668PubMedCrossRef
8.
9.
go back to reference Surwit RS, Feinglos MN, Rodin J et al (1995) Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 44:645–651PubMedCrossRef Surwit RS, Feinglos MN, Rodin J et al (1995) Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 44:645–651PubMedCrossRef
10.
go back to reference Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN (1988) Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37:1163–1167PubMedCrossRef Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN (1988) Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37:1163–1167PubMedCrossRef
11.
go back to reference Toye AA, Lippiat JD, Proks P et al (2005) A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice. Diabetologia 48:675–686PubMedCrossRef Toye AA, Lippiat JD, Proks P et al (2005) A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice. Diabetologia 48:675–686PubMedCrossRef
12.
go back to reference Wolfer DP, Crusio WE, Lipp HP (2002) Knockout mice: simple solutions to the problems of genetic background and flanking genes. Trends Neurosci 25:336–340PubMedCrossRef Wolfer DP, Crusio WE, Lipp HP (2002) Knockout mice: simple solutions to the problems of genetic background and flanking genes. Trends Neurosci 25:336–340PubMedCrossRef
13.
go back to reference Pi J, Bai Y, Daniel KW et al (2009) Persistent oxidative stress due to absence of uncoupling protein 2 associated with impaired pancreatic beta-cell function. Endocrinology 150:3040–3048PubMedCrossRef Pi J, Bai Y, Daniel KW et al (2009) Persistent oxidative stress due to absence of uncoupling protein 2 associated with impaired pancreatic beta-cell function. Endocrinology 150:3040–3048PubMedCrossRef
14.
go back to reference Hu F, Liu F (2011) Mitochondrial stress: a bridge between mitochondrial dysfunction and metabolic diseases? Cell Signal 23:1528–1533PubMedCrossRef Hu F, Liu F (2011) Mitochondrial stress: a bridge between mitochondrial dysfunction and metabolic diseases? Cell Signal 23:1528–1533PubMedCrossRef
15.
go back to reference Kraegen E, Cooney G, Ye JM, Furler S (2002) Peroxisome proliferator activated receptors, fatty acids and muscle insulin resistance. J Roy Soc Med 95:14–22PubMedCrossRef Kraegen E, Cooney G, Ye JM, Furler S (2002) Peroxisome proliferator activated receptors, fatty acids and muscle insulin resistance. J Roy Soc Med 95:14–22PubMedCrossRef
16.
go back to reference Samuel VT, Shulman GI (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148:852–871PubMedCrossRef Samuel VT, Shulman GI (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148:852–871PubMedCrossRef
17.
go back to reference Stump CS, Henriksen EJ, Wei Y, Sowers JR (2006) The metabolic syndrome: role of skeletal muscle metabolism. Ann Med 38:389–402PubMedCrossRef Stump CS, Henriksen EJ, Wei Y, Sowers JR (2006) The metabolic syndrome: role of skeletal muscle metabolism. Ann Med 38:389–402PubMedCrossRef
18.
go back to reference Turner N, Heilbronn LK (2008) Is mitochondrial dysfunction a cause of insulin resistance? Trends Endocrinol Metab 19:324–330PubMedCrossRef Turner N, Heilbronn LK (2008) Is mitochondrial dysfunction a cause of insulin resistance? Trends Endocrinol Metab 19:324–330PubMedCrossRef
19.
go back to reference Turner N, Bruce CR, Beale SM et al (2007) Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 56:2085–2092PubMedCrossRef Turner N, Bruce CR, Beale SM et al (2007) Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 56:2085–2092PubMedCrossRef
20.
go back to reference McLean JA, Tobin G (1987) Animal and human calorimetry. Cambridge University Press, Cambridge, p 352 McLean JA, Tobin G (1987) Animal and human calorimetry. Cambridge University Press, Cambridge, p 352
21.
go back to reference Ye JM, Iglesias MA, Watson DG et al (2003) PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly. Am J Physiol Endocrinol Metab 284:E531–E540 Ye JM, Iglesias MA, Watson DG et al (2003) PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly. Am J Physiol Endocrinol Metab 284:E531–E540
22.
go back to reference Matyash V, Liebisch G, Kurzchalia TV, Shevchenko A, Schwudke D (2008) Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res 49:1137–1146PubMedCrossRef Matyash V, Liebisch G, Kurzchalia TV, Shevchenko A, Schwudke D (2008) Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res 49:1137–1146PubMedCrossRef
23.
go back to reference Cleasby ME, Lau Q, Polkinghorne E et al (2011) The adaptor protein APPL1 increases glycogen accumulation in rat skeletal muscle through activation of the PI3-kinase signalling pathway. J Endocrinol 210:81–92PubMedCrossRef Cleasby ME, Lau Q, Polkinghorne E et al (2011) The adaptor protein APPL1 increases glycogen accumulation in rat skeletal muscle through activation of the PI3-kinase signalling pathway. J Endocrinol 210:81–92PubMedCrossRef
24.
go back to reference Turner N, Hariharan K, TidAng J et al (2009) Enhancement of muscle mitochondrial oxidative capacity and alterations in insulin action are lipid species dependent: potent tissue-specific effects of medium-chain fatty acids. Diabetes 58:2547–2554PubMedCrossRef Turner N, Hariharan K, TidAng J et al (2009) Enhancement of muscle mitochondrial oxidative capacity and alterations in insulin action are lipid species dependent: potent tissue-specific effects of medium-chain fatty acids. Diabetes 58:2547–2554PubMedCrossRef
25.
go back to reference Reznick J, Preston E, Wilks DL, Beale SM, Turner N, Cooney GJ (2012) Altered feeding differentially regulates circadian rhythms and energy metabolism in liver and muscle of rats. Biochim Biophys Acta. doi:10.1016/j.bbadis.2012.08.010 Reznick J, Preston E, Wilks DL, Beale SM, Turner N, Cooney GJ (2012) Altered feeding differentially regulates circadian rhythms and energy metabolism in liver and muscle of rats. Biochim Biophys Acta. doi:10.​1016/​j.​bbadis.​2012.​08.​010
26.
go back to reference Montgomery MK, Buttemer WA, Hulbert AJ (2012) Does the oxidative stress theory of aging explain longevity differences in birds? II. Antioxidant systems and oxidative damage. Exp Gerontol 47:211–222PubMedCrossRef Montgomery MK, Buttemer WA, Hulbert AJ (2012) Does the oxidative stress theory of aging explain longevity differences in birds? II. Antioxidant systems and oxidative damage. Exp Gerontol 47:211–222PubMedCrossRef
28.
go back to reference Levine RL, Garland D, Oliver CN et al (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464–478PubMedCrossRef Levine RL, Garland D, Oliver CN et al (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464–478PubMedCrossRef
29.
go back to reference Bou R, Codony R, Tres A, Decker EA, Guardicila F (2008) Determination of hydroperoxides in foods and biological samples by the ferrous oxidation-xylenol orange method: a review of the factors that influence the method's performance. Anal Biochem 377:1–15PubMedCrossRef Bou R, Codony R, Tres A, Decker EA, Guardicila F (2008) Determination of hydroperoxides in foods and biological samples by the ferrous oxidation-xylenol orange method: a review of the factors that influence the method's performance. Anal Biochem 377:1–15PubMedCrossRef
30.
go back to reference Even PC, Nadkarni NA (2012) Indirect calorimetry in laboratory mice and rats: principles, practical considerations, interpretation and perspectives. Am J Physiol Regul Integr Comp Physiol 303:R459–R476PubMedCrossRef Even PC, Nadkarni NA (2012) Indirect calorimetry in laboratory mice and rats: principles, practical considerations, interpretation and perspectives. Am J Physiol Regul Integr Comp Physiol 303:R459–R476PubMedCrossRef
31.
go back to reference Heikinnen S, Argmann CA, Champy MF, Auwerx J (2007) Evaluation of glucose homeostasis. Curr Prot Mol Biol 29B.3.1–29B.3.22 Heikinnen S, Argmann CA, Champy MF, Auwerx J (2007) Evaluation of glucose homeostasis. Curr Prot Mol Biol 29B.3.1–29B.3.22
32.
go back to reference Osborn O, Olefsky JM (2012) The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 18:363–374PubMedCrossRef Osborn O, Olefsky JM (2012) The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 18:363–374PubMedCrossRef
33.
go back to reference Eckardt K, Taube A, Eckel J (2011) Obesity-associated insulin resistance in skeletal muscle: role of lipid accumulation and physical inactivity. Rev Endocrinol Metab Dis 12:163–172CrossRef Eckardt K, Taube A, Eckel J (2011) Obesity-associated insulin resistance in skeletal muscle: role of lipid accumulation and physical inactivity. Rev Endocrinol Metab Dis 12:163–172CrossRef
34.
go back to reference Smith BW, Adams LA (2011) Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nat Rev Endocrinol 7:456–465PubMedCrossRef Smith BW, Adams LA (2011) Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nat Rev Endocrinol 7:456–465PubMedCrossRef
35.
go back to reference Kraegen EW, Cooney GJ (2008) Free fatty acids and skeletal muscle insulin resistance. Curr Opin Lipidol 19:235–241PubMedCrossRef Kraegen EW, Cooney GJ (2008) Free fatty acids and skeletal muscle insulin resistance. Curr Opin Lipidol 19:235–241PubMedCrossRef
36.
go back to reference Glatz JFC, Luiken J, Bonen A (2010) Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol Rev 90:367–417PubMedCrossRef Glatz JFC, Luiken J, Bonen A (2010) Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol Rev 90:367–417PubMedCrossRef
37.
go back to reference Samocha-Bonet D, Chisholm DJ, Tonks K, Campbell LV, Greenfield JR (2012) Insulin-sensitive obesity in humans: a ‘favorable fat’ phenotype? Trends Endocrinol Metab 23:116–124PubMedCrossRef Samocha-Bonet D, Chisholm DJ, Tonks K, Campbell LV, Greenfield JR (2012) Insulin-sensitive obesity in humans: a ‘favorable fat’ phenotype? Trends Endocrinol Metab 23:116–124PubMedCrossRef
38.
go back to reference Stefan N, Kantartzis K, Machann J et al (2008) Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 168:1609–1616PubMedCrossRef Stefan N, Kantartzis K, Machann J et al (2008) Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 168:1609–1616PubMedCrossRef
39.
go back to reference Collins S, Martin TL, Surwit RS, Robidoux J (2004) Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol Behav 81:243–248PubMedCrossRef Collins S, Martin TL, Surwit RS, Robidoux J (2004) Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol Behav 81:243–248PubMedCrossRef
40.
go back to reference Surwit RS, Seldin MF, Kuhn CM, Cochrane C, Feinglos MN (1991) Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetic C57BL/6J mice. Diabetes 40:82–87PubMedCrossRef Surwit RS, Seldin MF, Kuhn CM, Cochrane C, Feinglos MN (1991) Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetic C57BL/6J mice. Diabetes 40:82–87PubMedCrossRef
41.
go back to reference Hoehn KL, Salmon AB, Hohnen-Behrens C et al (2009) Insulin resistance is a cellular antioxidant defense mechanism. Proc Natl Acad Sci 106:17787–17792PubMedCrossRef Hoehn KL, Salmon AB, Hohnen-Behrens C et al (2009) Insulin resistance is a cellular antioxidant defense mechanism. Proc Natl Acad Sci 106:17787–17792PubMedCrossRef
42.
go back to reference Lee YS, Li PP, Huh JY et al (2011) Inflammation is necessary for long-term but not short-term high-fat diet induced insulin resistance. Diabetes 60:2474–2483PubMedCrossRef Lee YS, Li PP, Huh JY et al (2011) Inflammation is necessary for long-term but not short-term high-fat diet induced insulin resistance. Diabetes 60:2474–2483PubMedCrossRef
43.
go back to reference Strissel KJ, DeFuria J, Shaul ME, Bennett G, Greenberg AS, Obin MS (2010) T-Cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity 18:1918–1925PubMedCrossRef Strissel KJ, DeFuria J, Shaul ME, Bennett G, Greenberg AS, Obin MS (2010) T-Cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity 18:1918–1925PubMedCrossRef
44.
go back to reference Carter CP, Howles PN, Hui DY (1997) Genetic variation in cholesterol absorption efficiency among inbred strains of mice. J Nutr 127:1344–1348PubMed Carter CP, Howles PN, Hui DY (1997) Genetic variation in cholesterol absorption efficiency among inbred strains of mice. J Nutr 127:1344–1348PubMed
45.
go back to reference Keelan M, Hui DY, Wild G, Clandinin MT, Thomson AB (2000) Variability of the intestinal uptake of lipids is genetically determined in mice. Lipids 35:833–837PubMedCrossRef Keelan M, Hui DY, Wild G, Clandinin MT, Thomson AB (2000) Variability of the intestinal uptake of lipids is genetically determined in mice. Lipids 35:833–837PubMedCrossRef
46.
go back to reference Almind K, Kahn CR (2004) Genetic determinants of energy expenditure and insulin resistance in diet-induced obesity in mice. Diabetes 53:3274–3285PubMedCrossRef Almind K, Kahn CR (2004) Genetic determinants of energy expenditure and insulin resistance in diet-induced obesity in mice. Diabetes 53:3274–3285PubMedCrossRef
47.
go back to reference Nishikawa S, Sugimoto J, Okada M, Sakairi T, Takagi S (2012) Gene expression in livers of BALB/C and C57BL/6J mice fed a high-fat diet. Toxicol Pathol 40:71–82PubMedCrossRef Nishikawa S, Sugimoto J, Okada M, Sakairi T, Takagi S (2012) Gene expression in livers of BALB/C and C57BL/6J mice fed a high-fat diet. Toxicol Pathol 40:71–82PubMedCrossRef
48.
go back to reference Dumas ME, Barton RH, Toye A et al (2006) Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA 103:12511–12516PubMedCrossRef Dumas ME, Barton RH, Toye A et al (2006) Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA 103:12511–12516PubMedCrossRef
49.
go back to reference Shockley KR, Witmer D, Burgess-Herbert SL, Paigen B, Churchill GA (2009) Effects of atherogenic diet on hepatic gene expression across mouse strains. Physiol Genom 39:172–182CrossRef Shockley KR, Witmer D, Burgess-Herbert SL, Paigen B, Churchill GA (2009) Effects of atherogenic diet on hepatic gene expression across mouse strains. Physiol Genom 39:172–182CrossRef
Metadata
Title
Mouse strain-dependent variation in obesity and glucose homeostasis in response to high-fat feeding
Authors
M. K. Montgomery
N. L. Hallahan
S. H. Brown
M. Liu
T. W. Mitchell
G. J. Cooney
N. Turner
Publication date
01-05-2013
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 5/2013
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-2846-8

Other articles of this Issue 5/2013

Diabetologia 5/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.